Following on from the discussion about the US biosimilar landscape in the previous episode, CBPartners’ experts explore the trends and dynamics of the biosimilar market ex-USA – across the EU, Latin America and Asia Pacific regions, with a focus on:

•  Biosimilar availability and uptake in each region
•  Key barriers limiting biosimilar approval and uptake    
• Biosimilar manufacturer strategies to ensure successful launch